Anaesthesia-induced Rhabdomyolysis Causing Cardiac Arrest: Case Report and Review of Anaesthesia and the Dystrophinopathies

Rosenburg H. , Gronert G.A. Intractable cardiac arrest in children given succinylcholine. Anaesthesiology 1992 (C); 77: 1054.

Delphin E. , Jackson D. , Rothstein P. Use of succinylcholine during elective pediatric anaesthesia should be reevaluated. Anesth Analg 1987; 66: 1190–1192.

Tang T.T. , Oechler H.W. , Siker A.D. , Franciosi R.A. Anaesthesia induced rhabdomyolysis in infants with unsuspected Duchenne dystrophy. Acta Paediatr 1992; 81: 716–719.

Stelzner J. , Kretz F.J. , Rieger A. , Reinhart K. Anaesthesia induced cardiac arrest in two infants with unsuspected muscular dystrophy. Anaesthetist 1993; 42: 44–56.

Bennike K.A. , Jarum S. Myoglobinuria with acute renal failure possibly induced by suxamethonium. Br J Anaesth 1964; 36: 730–736.

McLaren C.A.B. Myoglobinuria following the use of suxamethonium chloride. Br J Anaesth 1968; 40: 901–902.

Genever E.E. Suxamethonium induced cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy. Br J Anaesth 1971; 43: 984–986.

Schaer H. , Steinmann B. , Jerusalem S. , Maier C. Rhabdomyolysis induced by anaesthesia with intraoperative cardiac arrest. Br J Anaesth 1977; 49: 495–499.

Seay A.R. , Ziter F.A. , Thompson J.A. Cardiac arrest during induction of anaesthesia in Duchenne muscular dystrophy. J Pediatrics 1978; 93: 88–90.

Miller E.D. , Sanders D.B. , Rowlinson J.C. , Berry F.A. , Sussman M.D. , Epstein R.M. Anaesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. Anesthesiology 1978; 48: 146–148.

Linter S.P.K. , Thomas P.R. , Withington P.S. , Hall M.G. Suxamethonium associated hypertonicity and cardiac arrest in unsuspected pesudohypertrophic muscular dystrophy. Br J Anaesth 1982; 54: 1331–1332.

McKishnie J.D. , Girvan D.P. Anaesthesia induced rhabdomyolysis. Can Anaesth Soc J 1983; 30: 295–298.

Henderson W.A.V. Succinylcholine induced cardiac arrest in unsuspected Duchenne muscular dystrophy. Can Anaesth Soc J 1984; 31: 444–446.

Rubiano R. , Chang J-L , Carroll J. , Sonbolian N. , Larson C.E. Acute rhabdomyolysis following halothane anaesthesia without succinylcholine. Anesthesiology 1987; 67: 856–857.

Chalkiadis G.A. , Branch K.G. Cardiac arrest after Isoflurane anaesthesia in a patient with Duchenne's muscular dystrophy. Anaesthesia 1990; 45: 22–25.

Dubowitz V. The muscular dystrophies. Postgrad Med J 1992; 68: 500–506.

Miller G. , Wessel H.B. Diagnosis of Dystrophinopathies: review for the Clinician. Pediatr Neurol 1993; 9: 3–9.

Bushby K.M.D. Recent advances in understanding muscular dystrophy. Arch. of Disease in Childhood 1992; 67: 1310–1312.

Medori R. , Brooke M.H. , Waterston R.H. Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations. Neurology 1989; 39: 461–465.

Baumbach L.L. , Chamberlain J.S. , Ward P.A. , Farwell N.J. , Caskey C.T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 1989; 39: 465–474.

Bushby K.M.D. , Thambyayah M. , Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337: 1022–1024.

Baudendistel L. , Goudsouzian N. , Cote C. , Strafford M. End-tidal CO₂ monitoring. Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia 1984; 39: 1000–1003.

Gronert G.A. , Fowler W. , Cardinet G.H. , Grix A. , Ellis W.G. , Schartz M.Z. Absence of malignant hyperthermia contractures in Becker-Duchenne dystrophy at age 2. Muscle Nerve 1992; 15: 52–56.

Ohlendick K. , Matsumura K. , Ionasescu V.V. Duchenne muscular dystrophy. Deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993; 43: 795–800.

Brownwell A.K.W. Malignant hyperthermia: relationship to other diseases. Br J Anaesth 1988; 60: 303–308.

Prendergast B.D. , George C.F. Drug-induced rhabdomyolysis—mechanisms and management. Postgrad Med J 1993; 69: 333–336.

Oka S. , Igarashi Y. , Takagi A. , Nishida M. , Sato K. , Nakada K. , Ikeda K. Malignant hyperpyrexia and Duchenne muscular dystrophy. A case report. Can Anaesth Soc J 1982; 29: 627–629.

Brownwell A.K.W. , Paasuke R.T. , Elash A. , Fowlow S.B. , Seagram C.G.F. , Diewold R.J. , Friesen C. Malignant Hyperthermia in Duchenne muscular dystrophy. Anesthesiology 1983; 58: 180–182.

Brownwell A.K.W. , Fowlow S.B. , Paasuke R.T. Coexistence of malignant hyperthermia and Duchenne muscular dystrophy in the same pedigree. Neurology 1985; 35 (Suppl 1): 195.

Tonin P. , Lewis P. , Servidei S. , DiMauro S. Metabolic causes of myoglobinurea. Ann Neurol 1990; 27: 181–185.

Lehmann-Horn F. , Iaizzo P.A. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 1990; 65: 692–697.

Ibraghimov-Beskrovnaya O. , Ervasti J.M. , Leveille C.I. , Slaughter C.A. , Sernett S.W. , Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992; 355: 696–702.

Hilton-Jones D. , Squier M.V. Muscular Dystrophy. Dystrophin-associated protein complex: Clinical implications. Lancet 1993; 341: 528–529.

Franco A. Jr , Lansman J.B. Calcium entry through stretch inactivated ion channels in mdx myotubules. Nature 1990; 344: 670–673.

Menke A. , Jockusch H. Decreased osmotic stability of dystrophin-less muscle cells from the MDX mouse. Nature 1991; 349-69–71.

Ryan J.F. , Kagen L.J. , Hyman A.I. Myoglobinuria after a single dose of succinylcholine. N Engl J Med 1971; 285: 824–827.

Tammisto T. , Airaksinen M. Increase of creatine kinase activity in serum as a sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia. Br J Anaesth 1966; 38: 510–515.

Fletcher J.E. , Rosenberg H. In vitro interaction between halothane and succinylcholine in human skeletal muscle: Implications for malignant hyperthermia and masseter muscle rigidity. Anesthesiology 1985; 63: 190–194.

Harrington J.F. , Ford D.J. , Striker T.W. Myoglobinuria after succinylcholine in children undergoing halothane and non-halothane anaesthesia. Anesthesiology 1984; 61: A431.

Worthan H.M. , Kuban K.C.K. , Sullivan K.F. , Brensan M.J. A national survey of anaesthetic complications in children with Duchenne's muscular dystrophy. Anesth Analg 1987; 66: S190.

Wang J.M. , Stanley T.H. Duchenne muscular dystrophy and malignant hyperthermia—two case reports. Can Anaesth Soc J 1986; 33: 492–497.

Smith C.L. , Bush G.H. Anaesthesia and progressive muscular dystrophy. Br J Anaesth 1985; 57: 1113–1118.

Azar I. The response of patients with neuromuscular disorders to muscle relaxants: A review. Anesthesiology 1984; 61: 173–187.

Sethna N.F. , Rockoff M.A. , Worthen H.M. , Rosnow J.M. Anaesthesia related complications in children with Duchenne muscular dystrophy. Anesthesiology 1988; 68: 462–465.

Richards W.C. Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseduohypertrophic muscular dystrophy. Anesth Intens Care 1972; 1: 150–153.

Hoffman E.P. , Fischbeck K.H. , Brown R.H. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988; 318: 1363–1368.

Littleford J.A. , Patel L.R. , Bose D. , Cameron C.B. , McKillop C. Masseter muscle spasm in children: Implications of continuing the triggering anaesthetic. Anesth Analg 1991; 72: 151–160.

Rosenburg H. , Shutack J.G. Masseter muscle spasm in children. (C) Anesth Analg 1991; 73: 361–362.